A detailed history of Sovereign Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sovereign Financial Group, Inc. holds 14,912 shares of BMY stock, worth $804,651. This represents 0.16% of its overall portfolio holdings.

Number of Shares
14,912
Previous 13,671 9.08%
Holding current value
$804,651
Previous $741,000 16.46%
% of portfolio
0.16%
Previous 0.2%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$40.25 - $52.99 $49,950 - $65,760
1,241 Added 9.08%
14,912 $619,000
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $21,830 - $24,752
455 Added 3.44%
13,671 $741,000
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $46,056 - $54,957
-950 Reduced 6.71%
13,216 $678,000
Q3 2023

Nov 03, 2023

SELL
$57.89 - $64.73 $79,830 - $89,262
-1,379 Reduced 8.87%
14,166 $822,000
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $58,358 - $64,797
916 Added 6.26%
15,545 $994,000
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $82,926 - $94,056
1,262 Added 9.44%
14,629 $1.01 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $99,775 - $118,148
1,457 Added 12.23%
13,367 $961,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $5 - $2,996
-39 Reduced 0.33%
11,910 $847,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $6,100 - $6,718
-84 Reduced 0.7%
11,949 $920,000
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $66,275 - $79,470
1,078 Added 9.84%
12,033 $879,000
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $4,129 - $4,814
77 Added 0.71%
10,955 $683,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $17,691 - $20,723
-299 Reduced 2.68%
10,878 $644,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $58,390 - $65,672
984 Added 9.65%
11,177 $706,000
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $588,543 - $666,927
10,193 New
10,193 $632,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sovereign Financial Group, Inc. Portfolio

Follow Sovereign Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sovereign Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sovereign Financial Group, Inc. with notifications on news.